drugset / Trial / NCT04963738
A Study of JNJ-73763989 in Adult Participants With Renal Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of a single subcutaneous (SC) dose of JNJ-73763989 in adult participants with renal impairment compared with healthy participants with normal renal function.
Timeline
- Start
- 2021-09-22
- Primary completion
- 2022-10-17
- Completion
- 2022-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-73763989 | Small interfering RNA (siRNA) | — | Subcutaneous |